ArticleScientific reports2024

Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers.

Peter Larsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.